We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Saturday
May 03
17:00 - 18:00
Stolz 2
Lung 3
Andreas Rimner, Germany;
VICTOR DUQUE-SANTANA, Spain
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
Lung
17:00 - 17:06
Clinical Outcomes for Surgery for Mesothelioma After Radiation Therapy using Extended pleural Resection (SMARTER Trial: NCT04028570)
John Cho, Canada
E25-4183
17:06 - 17:12
High Dose to Perfused but not Ventilated Lung is Associated with Clinical Toxicity
Neil Wallace, Australia
E25-4491
17:12 - 17:18
Impact of Prescribing to the PTV on GTV Dose Heterogeneity in lung SBRT: Insight from EORTC Studies.
Volha Hertsyk, Belgium
E25-2425
17:18 - 17:24
Radical Dose Re-Irradiation for Relapsed Non-Small Cell Lung Cancer; Real World Data on Impact of Guidelines and Survival Outcomes
Jin Howe Tee, United Kingdom
E25-3123
17:24 - 17:30
Effect of SABR on circulating tumor DNA detection in early-stage lung cancer: Interim results from a prospective, multi-center trial
Sympascho Young, Canada
E25-1556
17:30 - 17:36
Predicting tumour volume reduction in non-small cell lung cancer: Independent validation of a single parameter PSI model
Sarah Barrett, Ireland
E25-4506
17:36 - 17:42
Isolated nodal failure in stage III NSCLC after proton therapy in durvalumab era
Yuanyuan Lin, Spain
E25-1220
17:42 - 17:48
Lymphopenia induced by proton versus photon therapy in lung cancer: impact of dose to circulating lymphocytes, bone marrow and thoracic duct
Zuzanna Nowicka, Poland
E25-3731
17:54 - 18:00
Real world clinical outcomes for early-stage lung cancer treated with single-fraction stereotactic ablative radiotherapy in Australia
Jennifer Yeh, Australia
E25-3271